Deconex DM Interactions
There are 517 drugs known to interact with Deconex DM (dextromethorphan / guaifenesin / phenylephrine), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 87 are major, 427 are moderate, and 3 are minor.
- View all 517 medications that may interact with Deconex DM
- View Deconex DM alcohol/food interactions (1)
- View Deconex DM disease interactions (4)
Most frequently checked interactions
View interaction reports for Deconex DM (dextromethorphan / guaifenesin / phenylephrine) and the medicines listed below.
- albuterol
- alpha-lipoic acid
- amlodipine
- B Complex 50 (multivitamin)
- baclofen
- benzoyl peroxide / clindamycin topical
- Breo Ellipta (fluticasone / vilanterol)
- cefdinir
- cetirizine
- Derma-Smoothe / FS (fluocinolone topical)
- doxycycline
- Epiduo Forte (adapalene / benzoyl peroxide topical)
- folic acid
- gabapentin
- gentamicin topical
- Humira (adalimumab)
- Iron Sulfate (ferrous sulfate)
- leucovorin
- lidocaine topical
- methotrexate
- midodrine
- montelukast
- multivitamin
- naproxen
- Nasopen PE (phenylephrine / thonzylamine)
- olmesartan
- Otezla (apremilast)
- pantoprazole
- potassium citrate
- prednisone
Deconex DM alcohol/food interactions
There is 1 alcohol/food interaction with Deconex DM (dextromethorphan / guaifenesin / phenylephrine).
Deconex DM disease interactions
There are 4 disease interactions with Deconex DM (dextromethorphan / guaifenesin / phenylephrine) which include:
Report options
More about Deconex DM (dextromethorphan / guaifenesin / phenylephrine)
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.